4.3 Article

Effect of interferon beta-1a on B7.1 and B7.2 B-cell expression and its impact on T-cell proliferation

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 258, Issue 1-2, Pages 27-31

Publisher

ELSEVIER
DOI: 10.1016/j.jneuroim.2013.02.010

Keywords

Interferon beta; Peripheral blood mononuclear cell; B cell; B7.2; Costimulation; Multiple sclerosis

Funding

  1. EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany
  2. EMD Serono, Inc.
  3. Pfizer Inc.
  4. Pfizer Inc, New York, NY, USA

Ask authors/readers for more resources

The effect of pharmacologically relevant doses of interferon (IFN) beta-1a on B-cell expression of B7.1 and B7.2 was investigated. Culture of peripheral blood mononuclear cells with IFN beta-1a 100 IU/mL decreased B-cell expression of B7.1 and increased B7.2 expression. Interleukin-10 in B cells was significantly enhanced by IFN beta-1a. Anti-CD3 and anti-CD28 monoclonal antibody-mediated T-cell proliferations were partially suppressed in the presence of B cells pretreated with IFN beta-1a. These data suggest that IFN beta-1a and B cells can interact to play a beneficial role in the treatment of multiple sclerosis. (C) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available